Successful Management of Kaposiform Hemangioendothelioma with Kasabach‐Merritt Phenomenon Using Vincristine and Ticlopidine
Authors:
- 1 May 2009
- journal article
- case report
- Published by Wiley in Pediatric Dermatology
- Vol. 26 (3) , 365-366
Abstract
Kaposiform hemangioendothelioma is a rare locally aggressive vascular tumor that usually occurs in skin and retroperitoneum of infants and young children. We present a case of a newborn with a rapid tumor growth and a life-threatening Kasabach-Merritt syndrome with a progressive remission after treatment with vincristine and ticlopidine.Keywords
This publication has 5 references indexed in Scilit:
- Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach–Merritt phenomenon using four‐drug regimenPediatric Blood & Cancer, 2006
- Kasabach-Merritt Phenomenon: A Retrospective Study of Treatment with VincristineJournal of Pediatric Hematology/Oncology, 2002
- Kaposiform HemangioendotheliomaArchives of Dermatology, 1997
- Thrombocytopenic Coagulopathy (Kasabach-Merritt Phenomenon) Is Associated with Kaposiform Hemangioendothelioma and Not with Common Infantile HemangiomaPlastic and Reconstructive Surgery, 1997
- Kaposiform Hemangioendothelioma of Infancy and ChildhoodAmerican Journal of Surgical Pathology, 1993